Vincerx Pharma (VINC) announced its intention to file a Form 25 Notification of Delisting with the SEC on or about April 28, which will remove ...

In a turbulent market environment, VINC stock has reached its 52-week low, trading at $1.62, with technical indicators from InvestingPro showing the stock in oversold territory. This price level ...

SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global ...

Vincerx Pharma Inc (NASDAQ:VINC) shares are trading lower by 9.7% to $0.81 during Friday’s session after the company priced an underwritten public offering, including 6 million shares of common ...

Stay updated on market trends for VINC. US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert U.S. stock futures were volatile on ...

Find the latest Vincerx Pharma, Inc. VINC analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...